 |
|---|
| As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
|---|
|
|---|
2/11/14 Revance Therapeutics, Inc. 8-K:5,9 2/11/14 2:49K Donnelley … Solutions/FA
2/11/14 Glasheen James Walter 4 Director² 1:30K Revance Therapeutics, Inc. DONNELLEY FIN… File16/FA
2/11/14 Essex Woodlands Health… VIII-B LP 4 10% Owner² 1:43K Revance Therapeutics, Inc. DONNELLEY FIN… File16/FA
Essex Woodlands Health Ventures Fund VIII LP
Essex Woodlands Health Ventures Fund VIII-A LP
2/11/14 Gardner Phyllis 4 Director² 1:18K Revance Therapeutics, Inc. DONNELLEY FIN… File16/FA
2/11/14 Eastman Ronald W 4 Dir.,%Own.² 1:40K Revance Therapeutics, Inc. DONNELLEY FIN… File16/FA
2/11/14 Browne L Daniel 4 Dir.,Off.² 1:10K Revance Therapeutics, Inc. DONNELLEY FIN… File16/FA
2/11/14 Wooten Ronald J 4 Dir.,%Own.² 1:15K Revance Therapeutics, Inc. DONNELLEY FIN… File16/FA
2/11/14 Tunnicliffe Jonathan 4 Dir.,%Own.² 1:15K Revance Therapeutics, Inc. DONNELLEY FIN… File16/FA
2/11/14 NQ HCIF GP, Ltd. 4 10% Owner² 1:18K Revance Therapeutics, Inc. DONNELLEY FIN… File16/FA
NovaQuest Pharma Opportunities Fund III, L.P.
NQ HCIF General Partner, L.P.
| ____________ | | ¹ | Filing/Form Types: -K | | 4 | Statement of Changes in Beneficial Ownership of Securities by an Insider — Form 4 { The Filer is an Insider² of the Issuer }. | | 8-K | Current Report — Form 8-K { Item 1: Business & Operations; 2: Financial Info; 3: Securities & Trading; 4: Accountants & Accounting; 5: Governance & Management; 6: Asset-Backed Securities; 7: Disclosures; 8: Events; 9: Financials }. | | ² | Insider: The Filer is a Director, Officer, 10% Owner and/or Other “insider” of the Issuer. |
|
